Cardiovascular Thrombosis

Part 1 Fundamental considerations: thrombosis and fibrinolysis, Laurence A. Harker and Kenneth G. Mann; pathogenesis of thrombosis, Lina Badimon et al; interrelationship between atherosclerosis and thrombosis, Erling Falk et al; familial thrombophilia, Saskia Middeldorp et al; characteristics associated with the risk of arterial thrombosis, T.W. Meade et al; characteristics associated with the risk of venous thrombosis, Cedric J. Carter and Meyer Michel Samama; laboratory detection of the prethrombotic state, Piera Angelica et al. Part 2 Antithrombotic and thrombolytic drugs: antiplatelet drugs, Garrett A. Fitzgerald and Carlo Patrono; specific thrombin inhibitors, Marc Verstraete et al; specific factor anti-Xa inhibitors, Meyer M. Samama et al; unfractionated and low molecular weight heparin, Jack Hirsh and Christopher Granger; heparinoids, Walter Ageno and Alexander G.G. Turpie; dextran, David Nergqvist; other antithrombotics, Marc Verstraete; stable prostacyclin analogues, Jill J. Belch and Margaret McClaren; vitamin K antagonists, Eliot C. Williams and John W. Suttie; thrombolytic agents, H. Roger Lijnen et al; agents lowering blood viscosity, including defibrogenating agents, Gordon D.O. Lowe; mechanical thrombectomy approaches, Alexios P. Dimas and Patrick L. Whitlow; the technical aspects of antithrombotic approaches in vascular surgery, Michael D. Malone et al. Part 3 Prevention and treatment of thromboembolic disorders: antithrombotic therapy in valvular heart disease, James H. Chesebro and Valentin Fuster; prosthetic heart valves, Eric G. Butchart; thrombosis in cardiac chambers - ventricular dysfunction and atrial fibrillation, Jonathan L. Halperin and Palle Petersen; unstable angina, David J. Moliterno and Marc Cohen; antithrombotic agents in the secondary and primary prevention of cardiovascular diseases in high and usual risk, Patricia R. Hebert et al; acute phase treatment of myocardial infarction - selecting patients for thrombolysis, Frans J.J. Van de Werf and Eric J. Topol; prehospital treatment of acute myocardial infarction, Christopher P. Cannon; CCU treatment of acute myocardial infarction, Karl-Ludwig Neuhaus et al; adjunctive antithrombotic treatment to thrombolysis in acute myocardial infarction, David A. Vorchheimer and David V.M. Muller; complications of lytic and antithrombotic therapy in acute myocardial infarction, Maarten L. Simoons and Christopher B. Granger; antithrombotic treatment in the chronic phase of myocardial infarction, Pal J. Smith; coronary artery bypass surgery - antithrombotic therapy, James H. Chesebro and Steven Goldman; antithrombotic treatment in percutaneous transluminal coronary angioplasty and stenting, Michel E. Bertrand and Eric Van Belle; primary prevention of transcient ischaemic attack and thromboembolic stroke, Oscar Benavente et al; thrombolytic treatment of thrombotic stroke, Gregory J. del Zoppo and Werner Hacke. (Part contents)